Other studies have shown that SCN5A-positive Brugada syndrome patients have significant cardiomyopathic changes, primarily in the right ventricular outflow tract, such as fatty wall replacement, fibrosis, and reduced expression of connexin 43 [30,31,32]. Here, SCN5A is linked to Brugada syndrome.